ADVERTISEMENTREMOVE AD

Zydus Cadila’s COVID-19 Vaccine Gets Nod for Human Clinical Trials

Zydus Cadila’s COVID-19 Vaccine Gets Nod for Human Clinical Trials

Published
Fit
1 min read
story-hero-img
i
Aa
Aa
Small
Aa
Medium
Aa
Large
Hindi Female
ADVERTISEMENTREMOVE AD

Soon after Bharat Biotech’s Covaxin became the first indigenous vaccine candidate to get the nod for clinical trials, Ahmedabad’s Zydus Cadila Healthcare has also received the approval from the Drugs Controller General of India (DCGI) to conduct human trials for its vaccine, PTI reported quoting government sources.

An official source told the news agency,

This approval from the Drugs Controller General of India (DCGI) was fast-tracked after a recommendation received by the subject expert committee on COVID-19, in response to the ‘emergency and unmet medical need during the pandemic’.

“The phase I and II trials will take around three months to be completed,” the source added.

The company submitted the data of its clinical trials on animals to the regulator, where its vaccine candidate was reportedly found to be successful in terms of safety and immunogenicity.

Zydus Cadila is likely to enrol participants for the trials soon.

(At The Quint, we are answerable only to our audience. Play an active role in shaping our journalism by becoming a member. Because the truth is worth it.)

0

Read Latest News and Breaking News at The Quint, browse for more from fit

Topics:  Quint Fit 

Speaking truth to power requires allies like you.
Become a Member
3 months
12 months
12 months
Check Member Benefits
Read More
×
×